Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are aged 18 years or older but under 85 years old
- People who are scheduled to have a mastectomy (surgical removal of a breast) for a new breast cancer affecting one breast
Who may not be able to join:
- People who have had a previous breast cancer surgery with a cut larger than 2 cm
- People who have long-term dependence on opioid pain medicines, or who have been taking any regular pain medicines for more than 3 months
- People who have a medical reason that would make a specific type of nerve block (called an erector spinae plane block) unsafe — this includes active infection in the chest area, infection or cancer at the injection site, severe spine deformity, a history of spinal surgery, or serious blood-clotting problems (confirm with trial site)
- People who are unable to communicate before their operation due to severe dementia, serious hearing loss, language barriers, or advanced illness
- People who have a history of cancer in another part of the body, or who currently have cancer in another organ alongside their breast cancer
- People who have a history of heart disease (such as narrowed arteries, a previous heart attack, or previous heart procedures), significant liver or kidney problems before surgery, a history of stomach ulcers or bleeding, or who are classified as having very severe overall health problems under a standard medical rating system (ASA classification IV or above)
- People who have an allergy to a local anaesthetic medicine called ropivacaine
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dong-Xin Wang, M.D., Ph.D., Peking University First Hospital
Phone: +8618310161109
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of chronic postsurgical pain (CPSP) at 6 months after surgery; Progression-free survival (long-term outcomes)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.